APM
Avidity Partners Management Portfolio holdings
AUM
$499M
This Quarter Return
+7.36%
1 Year Return
+3.47%
3 Year Return
+181.12%
5 Year Return
+409%
10 Year Return
–
AUM
$499M
AUM Growth
+$499M
(+2.9%)
Cap. Flow
+$5.91M
Cap. Flow
% of AUM
1.19%
Top 10 Holdings %
Top 10 Hldgs %
49.06%
Holding
80
New
17
Increased
18
Reduced
13
Closed
25
Top Buys
| 1 |
HNGE
Hinge Health, Inc.
HNGE
|
$16.7M |
| 2 |
Intuitive Surgical
ISRG
|
$14.7M |
| 3 |
Natera
NTRA
|
$13.5M |
| 4 |
CG Oncology
CGON
|
$13.5M |
| 5 |
Genmab
GMAB
|
$13.4M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$16.1M |
| 2 |
Glaukos
GKOS
|
$13.2M |
| 3 |
Humana
HUM
|
$13.1M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$9.93M |
| 5 |
Neurocrine Biosciences
NBIX
|
$9.48M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Regenxbio
RGNX
$451M
| – | – | -260,000 | Closed | -$1.86M |
|
77
Royalty Pharma
RPRX
$15.6B
| – | – | -87,000 | Closed | -$2.71M |
|
78
United Therapeutics
UTHR
$13.8B
| – | – | -16,800 | Closed | -$5.18M |
|
79
Vera Therapeutics
VERA
$1.38B
| – | – | -91,000 | Closed | -$2.19M |
|
80
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | -94,000 | Closed | -$7.62M |
|